1. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada. Issue 6 (27th February 2015) Authors: Lourenço, L; Samji, H; Nohpal, A; Chau, W; Colley, G; Lepik, K; Barrios, R; Lima, V; Hogg, RS; Montaner, JSG; Kesselring, S; Moore, DM Journal: HIV medicine Issue: Volume 16:Issue 6(2015:Jul.) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV‐positive individuals in Canada. Issue 2 (1st September 2014) Authors: Samji, H; Taha, TE; Moore, D; Burchell, AN; Cescon, A; Cooper, C; Raboud, JM; Klein, MB; Loutfy, MR; Machouf, N; Tsoukas, CM; Montaner, JSG; Hogg, RS; Canadian Observational Cohort (CANOC) Collaboration; Aykroyd, G; Balfour, L; Bayoumi, A; Burchell, A; Cairney, J; Calzavara, L Journal: HIV medicine Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reductions in all‐cause and cause‐specific mortality among HIV‐infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001–20121. Issue 9 (9th June 2016) Authors: Cheung, CC; Ding, E; Sereda, P; Yip, B; Lourenco, L; Barrios, R; Montaner, JSG; Hogg, RS; Lima, V; Moore, DM Journal: HIV medicine Issue: Volume 17:Issue 9(2016:Oct.) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗